{
    "clinical_study": {
        "@rank": "56871", 
        "arm_group": {
            "arm_group_label": "All subjects", 
            "arm_group_type": "Other", 
            "description": "placebo histamine T1 T2 T3 T4 T5 T1-T2-T3 T4-T5"
        }, 
        "brief_summary": {
            "textblock": "Assessment of skin reactivity by skin prick tests to synthetic peptides derived from the\n      major birch allergen bet v 1, in subjects allergic to birch pollen."
        }, 
        "brief_title": "Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen", 
        "completion_date": {
            "#text": "June 2008", 
            "@type": "Actual"
        }, 
        "condition": "Allergic Rhinitis", 
        "condition_browse": {
            "mesh_term": "Rhinitis"
        }, 
        "detailed_description": {
            "textblock": "The study tested - all by skin tests - in the same group of 20 trial subjects, one positive\n      control (histamine solution), one negative control (placebo saline) and five experimental\n      peptides called T1, T2, T3, T4 and T5. Results of the skin prick tests were scored as\n      negative (no reaction) or positive (wheal diameter > 4 mm with erythema)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  history of allergy symptoms during previous birch pollen season\n\n          -  positive skin prick test to birch pollen extract\n\n        Exclusion Criteria:\n\n          -  pregnancy\n\n          -  uncontrolled asthma\n\n          -  other significant clinical conditions or immune disorders\n\n          -  subjects taking antihistamines or drugs with antihistamine activity"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01719133", 
            "org_study_id": "AN002"
        }, 
        "intervention": [
            {
                "arm_group_label": "All subjects", 
                "description": "saline solution", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug", 
                "other_name": "saline"
            }, 
            {
                "arm_group_label": "All subjects", 
                "description": "positive control", 
                "intervention_name": "Histamine", 
                "intervention_type": "Drug", 
                "other_name": "Histamine solution"
            }, 
            {
                "arm_group_label": "All subjects", 
                "description": "synthetic peptide T1", 
                "intervention_name": "AllerT1", 
                "intervention_type": "Drug", 
                "other_name": "AllerT1"
            }, 
            {
                "arm_group_label": "All subjects", 
                "description": "synthetic peptide T2", 
                "intervention_name": "AllerT2", 
                "intervention_type": "Drug", 
                "other_name": "AllerT2"
            }, 
            {
                "arm_group_label": "All subjects", 
                "description": "synthetic peptide T3", 
                "intervention_name": "AllerT3", 
                "intervention_type": "Drug", 
                "other_name": "AllerT3"
            }, 
            {
                "arm_group_label": "All subjects", 
                "description": "synthetic peptide T4", 
                "intervention_name": "AllerT4", 
                "intervention_type": "Drug", 
                "other_name": "AllerT4"
            }, 
            {
                "arm_group_label": "All subjects", 
                "description": "synthetic peptide T5", 
                "intervention_name": "AllerT5", 
                "intervention_type": "Drug", 
                "other_name": "AllerT5"
            }, 
            {
                "arm_group_label": "All subjects", 
                "description": "mix of peptides T1, T2 and T3", 
                "intervention_name": "mix of AllerT1-T2-T3", 
                "intervention_type": "Drug", 
                "other_name": "AllerT"
            }, 
            {
                "arm_group_label": "All subjects", 
                "description": "mix T4-T5", 
                "intervention_name": "mix of AllerT4-T5", 
                "intervention_type": "Drug", 
                "other_name": "mix T4-T5"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Histamine", 
                "Histamine phosphate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "allergy", 
            "birch"
        ], 
        "lastchanged_date": "October 31, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Lausanne", 
                    "country": "Switzerland"
                }, 
                "name": "Centre Hospitalier Universitaire Vaudois"
            }
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "1", 
        "official_title": "D\u00e9termination de la r\u00e9activit\u00e9 cutan\u00e9e de Volontaires Allergiques au Pollen de Bouleau Contre Des Peptides d\u00e9riv\u00e9s de Bet v 1", 
        "overall_official": {
            "affiliation": "Centre Hospitalier Universitaire Vaudois", 
            "last_name": "Francois Spertini, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Switzerland: Swissmedic", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "March 2008", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "skin prick test reactivity", 
            "safety_issue": "No", 
            "time_frame": "15 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01719133"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Anergis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Anergis", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2008", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}